- Home
- ADD vs MTEM Comparison
ADD vs MTEM Comparison
Compare ADD & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADD
- MTEM
- Stock Information
- Founded
- ADD 2002
- MTEM 2001
- Country
- ADD United States
- MTEM United States
- Employees
- ADD N/A
- MTEM N/A
- Industry
- ADD Engineering & Construction
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADD Consumer Discretionary
- MTEM Health Care
- Exchange
- ADD Nasdaq
- MTEM Nasdaq
- Market Cap
- ADD 10.3M
- MTEM 9.7M
- IPO Year
- ADD N/A
- MTEM N/A
- Fundamental
- Price
- ADD $5.69
- MTEM $0.47
- Analyst Decision
- ADD
- MTEM
- Analyst Count
- ADD 0
- MTEM 0
- Target Price
- ADD N/A
- MTEM N/A
- AVG Volume (30 Days)
- ADD 487.0K
- MTEM 15.9M
- Earning Date
- ADD 11-23-2024
- MTEM 11-19-2024
- Dividend Yield
- ADD N/A
- MTEM N/A
- EPS Growth
- ADD N/A
- MTEM N/A
- EPS
- ADD N/A
- MTEM N/A
- Revenue
- ADD $2,830,442.00
- MTEM $25,470,000.00
- Revenue This Year
- ADD N/A
- MTEM N/A
- Revenue Next Year
- ADD N/A
- MTEM N/A
- P/E Ratio
- ADD N/A
- MTEM N/A
- Revenue Growth
- ADD N/A
- MTEM N/A
- 52 Week Low
- ADD $0.06
- MTEM $0.30
- 52 Week High
- ADD $1.85
- MTEM $5.45
- Technical
- Relative Strength Index (RSI)
- ADD 95.49
- MTEM 44.19
- Support Level
- ADD $0.06
- MTEM $0.32
- Resistance Level
- ADD $0.17
- MTEM $1.13
- Average True Range (ATR)
- ADD 0.07
- MTEM 0.09
- MACD
- ADD 0.39
- MTEM 0.04
- Stochastic Oscillator
- ADD 90.68
- MTEM 22.72
About ADD Color Star Technology Co. Ltd.
Color Star Technology Co Ltd is an entertainment technology and education company providing online and offline music education. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.